Navigation Links
Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Date:2/14/2008

172,883 204,256

NON CURRENT PORTION OF CAPITAL LEASE

OBLIGATION - 41,641

DEFERRED REVENUE 5,261,840 5,726,131

LONG-TERM DEBT 9,520,800 -

------------------------------

Total liabilities 21,816,599 16,908,073

------------------------------

COMMITMENTS

STOCKHOLDER'S EQUITY

Common Stock, $0.001 par value,

100,000,000 shares authorized,

21,288,614 and 21,232,991 shares

issued and outstanding at

December 31, 2007 and

September 30, 2007, respectively 21,289 21,233

Warrants to purchase 66,390 shares of

common stock for $12.05 per share,

exercisable starting

September 30, 2007 526,720 526,720

Additional paid-in capital 116,633,456 115,518,201

Accumulated other comprehensive

income 4,405 4,405

Accumulated deficit (69,306,832) (57,134,233)

------------------------------

Total stockholders' equity 47,879,038 58,936,326

------------------------------

TOTAL $69,695,637 $75,844,399

==============================


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. CEL-SCI Corporation Reports First Quarter Financial Results
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
11. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Reportlinker.com ... available in its catalogue: mHealth and ... http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html Executive summary ... delivered, leading to better outcomes, decreased costs and ... for mHealth solutions is still in an early ...
(Date:7/30/2014)... KISSING, Germany , July 30, 2014 ... single use and computer-assisted ("robotic") colonoscopy system, today announced ... worldwide recognized medical device executive, as a new member ... is a highly respected global visionary in the medical ... as President and Chief Executive Officer at Given Imaging ...
(Date:7/30/2014)... and SAN DIEGO , July 30, ... ARNA ) announced today that an article based on ... lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and ... recently published in the online issue of Obesity , ... objective of these analyses was to identify whether there is ...
Breaking Medicine Technology:mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
... DUBLIN , March ... launch of a new product that allows life science ... and efficiently while,allowing greater collaboration across the process. PRISYM ... that need to design,validate and approve labelling on a ...
... March 22 QRS Diagnostic, proven leader ... announces its latest release of Office Medic™ (version 5.3) ... operating systems. Office Medic™ is in use by over ... between providers, diagnostic test data and electronic medical records ...
Cached Medicine Technology:PRISYM ID's Medica Greatly Simplifies FDA and MHRA Compliance 2PRISYM ID's Medica Greatly Simplifies FDA and MHRA Compliance 3PRISYM ID's Medica Greatly Simplifies FDA and MHRA Compliance 4QRS Diagnostic Releases 64-bit and Windows(R) 7 Compatible Software 2
(Date:7/30/2014)... during deployment, returning National Guard soldiers were more ... with civilian life setbacks, including job loss, legal ... commonplace in military families. Results of the study ... Public Health are published online in the ... abuse is a major concern for reservists returning ...
(Date:7/30/2014)... “United States Orthopedic Braces and Supports Market Outlook to ... Braces and Supports market. The report provides value, in millions ... data (in US dollars), within market categories:, ... and Supports , Spinal Braces and Supports , ... Orthotics is a specialty within the medical field concerned with ...
(Date:7/30/2014)... Within weeks freshman will begin to pour onto college ... will be a time of growth and the start to something ... may not be as easy as it looks. Some sources ... major at least once and many will switch two or three ... are exacerbated when switching in the later years of college. According ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Conducting ... Advanced Critical Thinking Skills and Innovative Techniques to ... Immel Resources and FDAnews**, Sept. 17-18, 2014 – ... been the #1 reason for 483 observations since ... clear: Developing a successful CAPA program has never ...
(Date:7/30/2014)... 2014 Good Neighbor Community Services ... upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , In this segment, ... Services’ vision to redefine the traditional approach to ... services. Through passion, innovation, determination, excellence, and collaboration, ...
Breaking Medicine News(10 mins):Health News:Vets' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 4Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2
... Pharmaceuticals intended for the treatment of minor illnesses of astronauts ... stable for long periods in the space environment. That,s ... Space Centre. Their findings, published online in The ... on space flights may have shorter shelf-life than they do ...
... judgments we make about the intimacy of other couples, ... serotonin, reports a new study published in Biological ... activity had been lowered, rated couples in photos as ... normal serotonin activity. The approach involved giving amino acid ...
... News) -- Home safety devices greatly reduce the number ... new study. Researchers at Cincinnati Children,s Hospital Medical ... One set of families had properly installed and maintained ... locks, electrical outlet covers, smoke alarms, carbon monoxide detectors, ...
... HealthDay Reporter , WEDNESDAY, April 13 (HealthDay News) ... in controlling and containing the spread of potentially lethal ... one study showed that certain interventions could decrease transmissions ... the other found no improvement when a somewhat different ...
... physicians affiliated with the Department of Obstetrics and Gynecology ... Medical School of Brown University were recently honored at ... Gynecology and Obstetrics (APGO). Urogynecologist B. Star Hampton, ... Martin L. Stone, MD, Fund for the Advancement of ...
... the Soviet Union, Russians were faced with more than the ... droves, and the country saw a 40 percent surge in ... alcohol that much was clear. And for years, many ... and capitalism for driving those men to drink. They reasoned ...
Cached Medicine News:Health News:Drug potency -- what happens in space? 2Health News:Serotonin: A critical chemical for human intimacy and romance 2Health News:With Safety Devices in Place, Kids' Injuries Decline: Study 2Health News:Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals 2Health News:Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals 3Health News:Stanford research casts sober light on Russia's mortality crisis 2Health News:Stanford research casts sober light on Russia's mortality crisis 3
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
With an intuitive operator interface, enhanced sample handling and innovative menu, the state-of-the-art Access 2 system delivers new levels of laboratory efficiency, standardization and cost effecti...
...
...
Medicine Products: